2023

1. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

   Parkinsonism and Related Disorders, Vol. 110

2. TAR DNA-Binding Protein 43 as a Potential Biomarker for Huntington’s Disease

   Contemporary Clinical Neuroscience (Springer Nature), pp. 351-366